US Stock MarketDetailed Quotes

GNTA Genenta Science

Watchlist

5.380
+0.600+12.55%

Close Nov 27 16:00 ET

98.40MMarket Cap-10466P/E (TTM)

Genenta Science Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-51.05%-11.21M

-6.61%-7.42M

-15.11%-6.96M

-142.74%-6.04M

-2.49M

Net income from continuing operations

-37.36%-11.65M

-53.32%-8.48M

1.12%-5.53M

-21.63%-5.59M

---4.6M

Operating gains losses

-16.23%75.69K

582.90%90.36K

118.48%13.23K

24.43%6.06K

--4.87K

Depreciation and amortization

591.42%42.45K

25.59%6.14K

157.32%4.89K

--1.9K

--0

Change In working capital

-273.78%-417.6K

112.36%240.3K

-111.15%-1.94M

-168.04%-920.72K

--1.35M

-Change in prepaid assets

-35.96%-554.04K

9.46%-407.49K

0.88%-450.09K

-400.54%-454.08K

--151.09K

-Change in payables and accrued expense

-147.58%-405.06K

168.33%851.32K

-358.72%-1.25M

-115.32%-271.59K

--1.77M

-Change in other current assets

239.50%596.94K

-44.76%-427.91K

-47.59%-295.6K

65.98%-200.29K

---588.68K

-Change in other current liabilities

-124.71%-55.44K

372.61%224.37K

805.51%47.48K

-71.25%5.24K

--18.24K

Cash from discontinued investing activities

Operating cash flow

-51.05%-11.21M

-6.61%-7.42M

-15.11%-6.96M

-142.74%-6.04M

---2.49M

Investing cash flow

Cash flow from continuing investing activities

-54,915.39%-14.89M

-200.48%-27.07K

56.83%-9.01K

-20.87K

Net PPE purchase and sale

49.05%-13.79K

-200.48%-27.07K

56.83%-9.01K

---20.87K

--0

Net investment purchase and sale

---14.88M

--0

----

Cash from discontinued investing activities

Investing cash flow

-54,915.39%-14.89M

-200.48%-27.07K

56.83%-9.01K

---20.87K

--0

Financing cash flow

Cash flow from continuing financing activities

531

1,968.80%28.74M

-90.59%1.39M

14.77M

Net common stock issuance

--531

--0

1,815.55%28.74M

-90.05%1.5M

--15.09M

Proceeds from stock option exercised by employees

--0

--543

--0

Net other financing activities

----

65.11%-111.12K

---318.51K

Cash from discontinued financing activities

Financing cash flow

--531

--0

1,968.80%28.74M

-90.59%1.39M

--14.77M

Net cash flow

Beginning cash position

-19.99%29.79M

140.80%37.24M

-23.22%15.47M

156.14%20.14M

--7.86M

Current changes in cash

-250.52%-26.1M

-134.19%-7.45M

565.66%21.77M

-138.09%-4.68M

--12.28M

Effect of exchange rate changes

---6.28K

--0

----

End cash Position

-87.61%3.69M

-19.99%29.79M

140.80%37.24M

-23.22%15.47M

--20.14M

Free cash flow

-50.68%-11.22M

-6.86%-7.45M

-14.87%-6.97M

-143.57%-6.07M

---2.49M

Currency Unit

EUR

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-51.05%-11.21M	-6.61%-7.42M	-15.11%-6.96M	-142.74%-6.04M	-2.49M
Net income from continuing operations	-37.36%-11.65M	-53.32%-8.48M	1.12%-5.53M	-21.63%-5.59M	---4.6M
Operating gains losses	-16.23%75.69K	582.90%90.36K	118.48%13.23K	24.43%6.06K	--4.87K
Depreciation and amortization	591.42%42.45K	25.59%6.14K	157.32%4.89K	--1.9K	--0
Change In working capital	-273.78%-417.6K	112.36%240.3K	-111.15%-1.94M	-168.04%-920.72K	--1.35M
-Change in prepaid assets	-35.96%-554.04K	9.46%-407.49K	0.88%-450.09K	-400.54%-454.08K	--151.09K
-Change in payables and accrued expense	-147.58%-405.06K	168.33%851.32K	-358.72%-1.25M	-115.32%-271.59K	--1.77M
-Change in other current assets	239.50%596.94K	-44.76%-427.91K	-47.59%-295.6K	65.98%-200.29K	---588.68K
-Change in other current liabilities	-124.71%-55.44K	372.61%224.37K	805.51%47.48K	-71.25%5.24K	--18.24K
Cash from discontinued investing activities
Operating cash flow	-51.05%-11.21M	-6.61%-7.42M	-15.11%-6.96M	-142.74%-6.04M	---2.49M
Investing cash flow
Cash flow from continuing investing activities	-54,915.39%-14.89M	-200.48%-27.07K	56.83%-9.01K	-20.87K	0
Net PPE purchase and sale	49.05%-13.79K	-200.48%-27.07K	56.83%-9.01K	---20.87K	--0
Net investment purchase and sale	---14.88M	--0	--0	----	----
Cash from discontinued investing activities
Investing cash flow	-54,915.39%-14.89M	-200.48%-27.07K	56.83%-9.01K	---20.87K	--0
Financing cash flow
Cash flow from continuing financing activities	531	0	1,968.80%28.74M	-90.59%1.39M	14.77M
Net common stock issuance	--531	--0	1,815.55%28.74M	-90.05%1.5M	--15.09M
Proceeds from stock option exercised by employees	--0	--0	--543	--0	--0
Net other financing activities	----	----	----	65.11%-111.12K	---318.51K
Cash from discontinued financing activities
Financing cash flow	--531	--0	1,968.80%28.74M	-90.59%1.39M	--14.77M
Net cash flow
Beginning cash position	-19.99%29.79M	140.80%37.24M	-23.22%15.47M	156.14%20.14M	--7.86M
Current changes in cash	-250.52%-26.1M	-134.19%-7.45M	565.66%21.77M	-138.09%-4.68M	--12.28M
Effect of exchange rate changes	---6.28K	--0	--0	----	----
End cash Position	-87.61%3.69M	-19.99%29.79M	140.80%37.24M	-23.22%15.47M	--20.14M
Free cash flow	-50.68%-11.22M	-6.86%-7.45M	-14.87%-6.97M	-143.57%-6.07M	---2.49M
Currency Unit	EUR	EUR	EUR	EUR	EUR
Audit Opinions	Unqualified Opinion	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data